With the increasing importance of generating large-scale data to drive new pharmaceutical and biotech discoveries, many scientists are feeling pressure to speed up data collection. One increasingly ...

The rising prevalence of infectious diseases, including emerging viral outbreaks, is a major factor fueling market growth. Additionally, increasing investments in precision medicine and personalized ...

The portable PCR (Polymerase Chain Reaction) systems market is witnessing significant growth, driven by the increasing demand for rapid, accurate, and on-site diagnostic solutions. These compact and ...

Targeting users that demand greater performance, the new system offers better specifications over the Clarity™ system, which is the first digital PCR product commercialised by the company. The new ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, ...

Once submitted, we will try and place you in contact with a suitable Real-Time PCR Systems supplier within 48 hours.

The CFX Opus 96 Dx System and the CFX Opus 384 Dx System are the latest additions to Bio-Rad’s portfolio of real-time PCR instruments. The systems offer quantification to improve assay development, ...

Bio-Rad will be launching two new real-time PCR detection tools to be used for in-vitro diagnostic testing. Bio-Rad Laboratories, a life science research and clinical diagnostics product provider, ...

QIAGEN N.V. announced the development of a range of next-generation systems for digital polymerase chain reaction (digital PCR or dPCR), one of the fastest-growing molecular testing applications in ...

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the development of a range of next-generation systems for digital polymerase ...